Abstract
Candida famata, once regarded as benign, is now being recognized as an opportunistic pathogen. This case presents an 88-year-old male with multiple comorbidities who developed C. famata bloodstream infection during treatment for healthcare-associated pneumonia complicated by prolonged catheter use and hospital stay. Antifungal therapy with voriconazole led to clinical improvement and eventual discharge of the patient in stable condition. The rarity of C. famata infection presents diagnostic and therapeutic challenges. This case highlights the importance of timely antifungal therapy and a multidisciplinary approach in managing invasive candidiasis, particularly in immunocompromised patients. Further research is needed to optimize treatment.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call